In vitro susceptibility of Salmonella enterica serovar Typhi to ceftolozane/tazobactam

J Antimicrob Chemother. 2019 Feb 1;74(2):528-530. doi: 10.1093/jac/dky418.

Authors

Elaine Chan¹, Alan K L Wu², Cindy W S Tse³, Susanna K P Lau^{1

4}, Patrick C Y Woo^{1

4}

Affiliations

¹ Department of Microbiology, The University of Hong Kong, Hong Kong, China.
² Department of Clinical Pathology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China.
³ Department of Pathology, Kwong Wah Hospital, Hong Kong, China.
⁴ Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The University of Hong Kong, Hong Kong, China.

PMID: 30295743
DOI: 10.1093/jac/dky418

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Cephalosporins / pharmacology*
Feces / microbiology
Humans
Microbial Sensitivity Tests
Salmonella typhi / drug effects*
Tazobactam / pharmacology*
Typhoid Fever / microbiology

Substances

Cephalosporins
ceftolozane, tazobactam drug combination
Tazobactam